| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.047 | 0.4 |